United States · FDA National Drug Code directory
carbamazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-556_ce978022-a6e7-4be2-8794-18ecc1fd6725
- Product NDC
- 68382-556
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- carbamazepine
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190312
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBAMAZEPINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-01) · 68382-556-01
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-06) · 68382-556-06
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-556-16) · 68382-556-16
- 10 BLISTER PACK in 1 CARTON (68382-556-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 68382-556-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →